NYU Langone Health
New York, 10016, United States
Location status: Recruiting
Location contact
Sam Parnia, MD, PhD
PRINCIPAL_INVESTIGATOR
NCT Number: NCT05234866
Cognitive decline in dementia is considered irreversible, however episodes of paradoxical lucidity (PL) in severe dementia suggest other mechanisms may be in play. Beyond anecdotal reports of transient PL events occurring in patients predominantly in late-stage dementia and typically lasting anywhere from a few minutes to several hours, little is known about PL. The study team proposes to develop and conduct a mixed methods prospective study of PL during end stage advanced dementia, creating a definition and measurement scale for PL in advanced dementia, and identifying the potential electro cortical biomarkers of PL in advanced dementia. This study will be divided in two phases: Phase I and Phase II. During Phase I, the study team will collect sufficient and necessary data through an online survey and focus groups as well as assess the safety and feasibility of using symptom diaries (also known as daily trackers or journals) and real-time video EEG monitoring (vEEG). After preliminary review of the study procedures, the PI will decide whether to move onto the Phase II. The second phase will aim to expand the study population and refine study methods as well as create a definition and measurement scale for PL in advances dementia.
Interested in participating?
Request Info18 year and older
All sexes
Observational
New York, 10016, United States
Location status: Recruiting
Sam Parnia, MD, PhD
PRINCIPAL_INVESTIGATOR
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: up to Day 7
Time frame: up to Day 7
Time frame: up to Day 7
Time frame: up to Day 7
Time frame: up to Day 7
Time frame: up to Day 7
Time frame: up to Day 7
Time frame: up to Day 7
Time frame: up to Day 7
Time frame: Baseline, up to Day 7
Time frame: Baseline, up to Day 7
Contact information is provided by the study sponsor or research team.
Natalia Leontovich
CONTACT
Sam Parnia, MD, PhD
CONTACT
NYU Langone Health
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT02014246
Brain Diseases, Central Nervous System Diseases
Baltimore, Maryland, United States
View Trial DetailsNCT07730957
Aberrant Motor Behavior in Dementia, Behavior
Amiens, France
View Trial DetailsNCT05552157
Alzheimer Disease, Alzheimers Disease
Birmingham, Alabama, United States
View Trial DetailsNCT06647498
Alzheimer Disease, Alzheimers Disease
Birmingham, Alabama, United States
View Trial Details